Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
- PMID: 37623239
- PMCID: PMC10453126
- DOI: 10.3390/cimb45080420
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
Abstract
Oxidative stress is a critical factor in the pathogenesis and progression of diabetes and its associated complications. The imbalance between reactive oxygen species (ROS) production and the body's antioxidant defence mechanisms leads to cellular damage and dysfunction. In diabetes, chronic hyperglycaemia and mitochondrial dysfunction contribute to increased ROS production, further exacerbating oxidative stress. This oxidative burden adversely affects various aspects of diabetes, including impaired beta-cell function and insulin resistance, leading to disrupted glucose regulation. Additionally, oxidative stress-induced damage to blood vessels and impaired endothelial function contribute to the development of diabetic vascular complications such as retinopathy, nephropathy, and cardiovascular diseases. Moreover, organs and tissues throughout the body, including the kidneys, nerves, and eyes, are vulnerable to oxidative stress, resulting in diabetic nephropathy, neuropathy, and retinopathy. Strategies to mitigate oxidative stress in diabetes include antioxidant therapy, lifestyle modifications, and effective management of hyperglycaemia. However, further research is necessary to comprehensively understand the underlying mechanisms of oxidative stress in diabetes and to evaluate the efficacy of antioxidant interventions in preventing and treating diabetic complications. By addressing oxidative stress, it might be possible to alleviate the burden of diabetes and improve patient outcomes.
Keywords: Mediterranean diet; diabetes complications; diet; lifestyle modifications; oxidative stress; physical activity; type 2 diabetes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10453126/bin/cimb-45-00420-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10453126/bin/cimb-45-00420-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10453126/bin/cimb-45-00420-g003.gif)
Similar articles
-
Role of oxidative stress in diabetes-induced complications and their management with antioxidants.Arch Physiol Biochem. 2023 Aug 11:1-26. doi: 10.1080/13813455.2023.2243651. Online ahead of print. Arch Physiol Biochem. 2023. PMID: 37571852 Review.
-
The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications.Front Endocrinol (Lausanne). 2023 Feb 7;14:1112363. doi: 10.3389/fendo.2023.1112363. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36824356 Free PMC article. Review.
-
Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives.Free Radic Biol Med. 2022 May 1;184:114-134. doi: 10.1016/j.freeradbiomed.2022.03.019. Epub 2022 Apr 7. Free Radic Biol Med. 2022. PMID: 35398495 Review.
-
Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.Redox Biol. 2020 Oct;37:101799. doi: 10.1016/j.redox.2020.101799. Epub 2020 Nov 13. Redox Biol. 2020. PMID: 33248932 Free PMC article. Review.
-
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review.
Cited by
-
Diabetes and Stroke: Impact of Novel Therapies for the Treatment of Type 2 Diabetes Mellitus.Biomedicines. 2024 May 16;12(5):1102. doi: 10.3390/biomedicines12051102. Biomedicines. 2024. PMID: 38791064 Free PMC article. Review.
-
Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome.Pharmaceuticals (Basel). 2024 Apr 19;17(4):525. doi: 10.3390/ph17040525. Pharmaceuticals (Basel). 2024. PMID: 38675485 Free PMC article.
-
Antidiabetic Properties of the Root Extracts of Dandelion (Taraxacum officinale) and Burdock (Arctium lappa).Plants (Basel). 2024 Apr 3;13(7):1021. doi: 10.3390/plants13071021. Plants (Basel). 2024. PMID: 38611548 Free PMC article.
-
Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes.Heliyon. 2024 Mar 29;10(7):e28921. doi: 10.1016/j.heliyon.2024.e28921. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38596141 Free PMC article.
-
Genetic and Transcriptomic Background of Oxidative Stress and Antioxidative Therapies in Late Complications of Type 2 Diabetes Mellitus: A Systematic Review.Antioxidants (Basel). 2024 Feb 24;13(3):277. doi: 10.3390/antiox13030277. Antioxidants (Basel). 2024. PMID: 38539811 Free PMC article. Review.
References
-
- Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
-
- Salvatore T., Galiero R., Caturano A., Vetrano E., Rinaldi L., Coviello F., Di Martino A., Albanese G., Colantuoni S., Medicamento G., et al. Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes. Biomolecules. 2022;12:176. doi: 10.3390/biom12020176. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources